Whats the difference between TOBI and compounded IV solutions of tobramycin used for inhalation?
TOBI is the only tobramycin solution approved by the Food and Drug Administration (FDA) for inhalation in patients with cystic fibrosis and Pseudomonas aeruginosa infection. It is approved for people aged 6 and over with a lung function within a certain range. TOBI is free from preservatives . Compounded IV solutions of tobramycin not approved for inhalation by the FDA may not be free from preservatives.